Post-earnings recap
Reported
Thu, Feb 27, 2025
EPS actual
$0.01
EPS est.
$0.03
EPS surprise
-62.96%
1-day move
-5.03%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Aurinia Pharmaceuticals reported a lower-than-expected EPS of $0.01, which contributed to a 5.03% decline in stock price. The lack of revenue figures and guidance may raise concerns among investors about the company's performance and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.01 | N/A | -62.96% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based solely on numerical results.